WFIN.AS vs. XGEN.DE

Last updated Jun 4, 2026

WFIN.AS (SPDR MSCI World Financials UCITS ETF) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both exchange-traded funds - WFIN.AS is a Financials Equities fund tracking the MSCI World/Financials NR USD, while XGEN.DE is a Health & Biotech Equities fund tracking the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, WFIN.AS returned 19.91%/yr vs 0.11%/yr for XGEN.DE. A 0.52 correlation means they provide meaningful diversification when combined. Both charge a 0.30% expense ratio.

Performance

WFIN.AS vs. XGEN.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in SPDR MSCI World Financials UCITS ETF (WFIN.AS) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, WFIN.AS achieves a -0.53% return, which is significantly higher than XGEN.DE's -5.12% return.

WFIN.AS

• 1D: -1.10%
• 1M: 0.74%
• YTD: -0.53%
• 6M: 3.66%
• 1Y: 10.32%
• 3Y*: 19.91%
• 5Y*: 12.40%
• 10Y*: 11.76%

XGEN.DE

• 1D: 0.55%
• 1M: 3.08%
• YTD: -5.12%
• 6M: -7.29%
• 1Y: 19.19%
• 3Y*: 0.11%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

WFIN.AS vs. XGEN.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
WFIN.AS SPDR MSCI World Financials UCITS ETF	-0.53%	14.32%	35.51%	11.89%	2.85%
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	-5.12%	7.38%	2.95%	-5.84%	-9.98%

Correlation

The correlation between WFIN.AS and XGEN.DE is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.41
Correlation (3Y) Calculated over the trailing 3-year period	0.52
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022	0.52

The correlation between WFIN.AS and XGEN.DE shifts across timeframes, from 0.41 (1 year) to 0.52 (all time), reflecting how their relationship changes across market environments.

Return for Risk

WFIN.AS vs. XGEN.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WFIN.AS

WFIN.AS Risk / Return Rank: 23
WFIN.AS Sharpe Ratio Rank: 23
WFIN.AS Sortino Ratio Rank: 23
WFIN.AS Omega Ratio Rank: 21
WFIN.AS Calmar Ratio Rank: 23
WFIN.AS Martin Ratio Rank: 25

XGEN.DE

XGEN.DE Risk / Return Rank: 27
XGEN.DE Sharpe Ratio Rank: 30
XGEN.DE Sortino Ratio Rank: 30
XGEN.DE Omega Ratio Rank: 27
XGEN.DE Calmar Ratio Rank: 27
XGEN.DE Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WFIN.AS vs. XGEN.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR MSCI World Financials UCITS ETF (WFIN.AS) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WFIN.AS	XGEN.DE	Difference
Sharpe ratio: Return per unit of total volatility	0.80	1.07	-0.27
Sortino ratio: Return per unit of downside risk	1.21	1.62	-0.41
Omega ratio: Gain probability vs. loss probability	1.14	1.18	-0.04
Calmar ratio: Return relative to maximum drawdown	1.06	1.27	-0.22
Martin ratio: Return relative to average drawdown	3.27	3.10	+0.16
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WFIN.AS vs. XGEN.DE - Sharpe Ratio Comparison

The current WFIN.AS Sharpe Ratio is 0.80, which is comparable to the XGEN.DE Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of WFIN.AS and XGEN.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	WFIN.AS	XGEN.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.80	1.07	-0.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.75	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.60	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	-0.16	+0.35

Drawdowns

WFIN.AS vs. XGEN.DE - Drawdown Comparison

The maximum WFIN.AS drawdown since its inception was -72.88%, which is greater than XGEN.DE's maximum drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for WFIN.AS and XGEN.DE.

Drawdown Indicators

	WFIN.AS	XGEN.DE	Difference
Max Drawdown Largest peak-to-trough decline	-72.88%	-37.58%	-35.30%
Max Drawdown (1Y) Largest decline over 1 year	-9.65%	-14.99%	+5.34%
Max Drawdown (3Y) Largest decline over 3 years	-19.52%	-28.21%	+8.69%
Max Drawdown (5Y) Largest decline over 5 years	-19.52%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-42.00%	—	—
Current Drawdown Current decline from peak	-2.75%	-18.07%	+15.32%
Average Drawdown Average peak-to-trough decline	-18.72%	-19.44%	+0.72%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.12%	6.17%	-3.05%

Volatility

WFIN.AS vs. XGEN.DE - Volatility Comparison

The current volatility for SPDR MSCI World Financials UCITS ETF (WFIN.AS) is 3.08%, while Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) has a volatility of 5.36%. This indicates that WFIN.AS experiences smaller price fluctuations and is considered to be less risky than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WFIN.AS	XGEN.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.08%	5.36%	-2.28%
Volatility (6M) Calculated over the trailing 6-month period	9.49%	13.16%	-3.67%
Volatility (1Y) Calculated over the trailing 1-year period	12.72%	17.84%	-5.12%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.17%	18.56%	-2.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.44%	18.56%	+0.88%

WFIN.AS vs. XGEN.DE - Expense Ratio Comparison

Both WFIN.AS and XGEN.DE have an expense ratio of 0.30%.

Dividends

WFIN.AS vs. XGEN.DE - Dividend Comparison

Neither WFIN.AS nor XGEN.DE has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both WFIN.AS and XGEN.DE in my portfolio?

WFIN.AS and XGEN.DE have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, WFIN.AS or XGEN.DE?

Both ETFs have the same 0.30% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, WFIN.AS or XGEN.DE?

WFIN.AS and XGEN.DE have the same expense ratio: 0.30% per year.

What is the main difference between WFIN.AS and XGEN.DE?

WFIN.AS is categorized as Financials Equities, while XGEN.DE is Health & Biotech Equities. WFIN.AS tracks MSCI World/Financials NR USD, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. They also come from different issuers: State Street and Xtrackers.